Literature DB >> 27884355

Statistical Approaches to Composite Endpoints.

William S Weintraub1.   

Abstract

Entities:  

Keywords:  composite endpoints; outcomes; statistics

Mesh:

Year:  2016        PMID: 27884355      PMCID: PMC5773256          DOI: 10.1016/j.jcin.2016.08.047

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  13 in total

1.  A tale of coronary artery disease and myocardial infarction.

Authors:  Elizabeth G Nabel; Eugene Braunwald
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

Review 2.  Estimating causal effects from large data sets using propensity scores.

Authors:  D B Rubin
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

3.  Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

Authors:  Davide Capodanno; Giuseppe Gargiulo; Sergio Buccheri; Alaide Chieffo; Emanuele Meliga; Azeem Latib; Seung-Jung Park; Yoshinobu Onuma; Piera Capranzano; Marco Valgimigli; Inga Narbute; Raj R Makkar; Igor F Palacios; Young-Hak Kim; Pawel E Buszman; Tarun Chakravarty; Imad Sheiban; Roxana Mehran; Christoph Naber; Ronan Margey; Arvind Agnihotri; Sebastiano Marra; Martin B Leon; Jeffrey W Moses; Jean Fajadet; Thierry Lefèvre; Marie-Claude Morice; Andrejs Erglis; Ottavio Alfieri; Patrick W Serruys; Antonio Colombo; Corrado Tamburino
Journal:  JACC Cardiovasc Interv       Date:  2016-11-28       Impact factor: 11.195

4.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

5.  Comparative effectiveness of revascularization strategies.

Authors:  William S Weintraub; Maria V Grau-Sepulveda; Jocelyn M Weiss; Sean M O'Brien; Eric D Peterson; Paul Kolm; Zugui Zhang; Lloyd W Klein; Richard E Shaw; Charles McKay; Laura L Ritzenthaler; Jeffrey J Popma; John C Messenger; David M Shahian; Frederick L Grover; John E Mayer; Cynthia M Shewan; Kirk N Garratt; Issam D Moussa; George D Dangas; Fred H Edwards
Journal:  N Engl J Med       Date:  2012-03-27       Impact factor: 91.245

6.  The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.

Authors:  Stuart J Pocock; Cono A Ariti; Timothy J Collier; Duolao Wang
Journal:  Eur Heart J       Date:  2011-09-06       Impact factor: 29.983

7.  Modelling recurrent events: a tutorial for analysis in epidemiology.

Authors:  Leila D A F Amorim; Jianwen Cai
Journal:  Int J Epidemiol       Date:  2014-12-09       Impact factor: 7.196

8.  Weighting composite endpoints in clinical trials: essential evidence for the heart team.

Authors:  Betty C Tong; Joel C Huber; Deborah D Ascheim; John D Puskas; T Bruce Ferguson; Eugene H Blackstone; Peter K Smith
Journal:  Ann Thorac Surg       Date:  2012-07-12       Impact factor: 4.330

Review 9.  Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.

Authors:  Gloria Cordoba; Lisa Schwartz; Steven Woloshin; Harold Bae; Peter C Gøtzsche
Journal:  BMJ       Date:  2010-08-18

10.  Competing risks analyses: objectives and approaches.

Authors:  Marcel Wolbers; Michael T Koller; Vianda S Stel; Beat Schaer; Kitty J Jager; Karen Leffondré; Georg Heinze
Journal:  Eur Heart J       Date:  2014-04-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.